Erratum: Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury (Journal of the Renin-Angiotensin-Aldosterone System (2016) 1: 8 DOI: 10.1177/1470320316661871);Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 17, Issue 3, 2016, Pages I-

  Ali, Quaisar ^a   Dhande, Isha ^a   Samuel, Preethi ^a   Hussain, Tahir ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Angiotensin (1 7); Angiotensin II type 2 receptor knockout; Mas receptor; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; MAS RECEPTOR; RECEPTOR; RENIN; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENE DELETION; KIDNEY CORTEX; KIDNEY INJURY; KNOCKOUT MOUSE; LIPID DIET; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MESANGIUM; MICROALBUMINURIA; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; WILD TYPE MOUSE; ANIMAL; BLOOD PRESSURE; INJURIES; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; SYSTOLE;

ANGIOTENSIN I; ANIMALS; BIOMARKERS; BLOOD PRESSURE; CHROMATOGRAPHY, LIQUID; DIET, HIGH-FAT; GENE DELETION; KIDNEY; MALE; MASS SPECTROMETRY; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, G-PROTEIN-COUPLED; RENIN; RENIN-ANGIOTENSIN SYSTEM; SYSTOLE;

EID: 84983238503     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320317699     Document Type: Erratum

References (43)

1. Hollenberg NK. The renin-angiotensin system and sodium homeostasis. Cardiovasc Pharmacol 1984; 6: S176-S183
2. MacGregor GA, Markandu ND, Roulston JE, et al. The renin-angiotensin-aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects. Clin Sci (Lond) 1980; 59: 95s-99s
3. Fraune C, Lange S, Krebs C, et al. AT1 antagonism and renin inhibition in mice: Pivotal role of targeting angiotensin II in chronic kidney disease. Am J Physiol Renal Physiol 2012; 303: F1037-F1048
4. Tallam LS and Jandhyala BS. Exaggerated natriuresis after selective AT1 receptor blockade in Dahl salt-sensitive rats. Clin Exp Hypertens 2001; 23: 623-631
5. de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-472
6. Kangussu LM, Guimaraes PS, Nadu AP, et al. Activation of angiotensin-(1-7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats. Neuropharmacology 2015; 97: 58-66
7. Shi Y, Lo CS, Padda R, et al. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clin Sci 2015; 128: 649-663
8. Ali Q, Wu Y and Hussain T. Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats. Kidney Int 2013; 84: 931-939
9. Shenoy V, Kwon KC, Rathinasabapathy A, et al. Oral delivery of angiotensin-converting enzyme 2 and angiotensin-( 1-7) bioencapsulated in plant cells attenuates pulmonary hypertension. Hypertension 2014; 64: 1248-1259
10. Martins Lima A, Xavier CH, Ferreira AJ, et al. Activation of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute emotional stress. Am J Physiol Heart Circ Physiol 2013; 305: H1057-H1067
11. Gallagher PE, Ferrario CM and Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 2008; 295: H2373-H2379
12. Ohshima K, Mogi M, Nakaoka H, et al. Possible role of angiotensin- converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade. Hypertension 2014; 63: e53-e59
13. Zhang Y, Li B, Wang B, Zhang J, et al. Alteration of cardiac ACE2/Mas expression and cardiac remodelling in rats with aortic constriction. Chin J Physiol 2014; 57: 335-342
14. Iwanami J, Mogi M, Tsukuda K, et al. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan. Hypertens Res 2014; 37: 616-620
15. Ali Q and Hussain T. AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats. Hypertens Res 2012; 35: 654-660
16. Dhande I, Ali Q and Hussain T. Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: Role in renoprotection in obese rats. Hypertension 2013; 61: 1218-1226
17. Kemp BA, Howell NL, Gildea JJ, et al. AT(2) receptor activation induces natriuresis and lowers blood pressure. Circ Res 2014; 115: 388-399
18. Hilliard LM, Jones ES, Steckelings UM, et al. Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: A novel therapeutic target for hypertension. Hypertension 2012; 59: 409-414
19. AbdAlla S, Lother H, Abdel-tawab AM, et al. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001; 276: 39721-39726
20. Miura S, Matsuo Y, Kiya Y, et al. Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors. Biochem Biophy Res Commun 2010; 391: 85-90
21. Ferrao FM, Lara LS, Axelband F, et al. Exposure of luminal membranes of LLC-PK1 cells to ANG II induces dimerization of AT1/AT2 receptors to activate SERCA and to promote Ca2+ mobilization. Am J Physiol Renal Physiol 2012; 302: F875-F883
22. Ali Q, Patel S and Hussain T. Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats. Am J Physiol Renal Physiol 2015; 308: F1379-F1385
23. Samuel P, Ali Q, Sabuhi R, et al. High Na-intake increases renal angiotensin II levels and reduces the expression of ACE2-AT2R-MasR axis in obese Zucker rats. Am J Physiol Renal Physiol 2012; 303: F412-F419
24. Ali Q, Wu Y, Nag S, et al. Estimation of angiotensin peptides in biological samples by LC/MS method. Anal Methods 2014; 6: 215-222
25. Raij L, Azar S and Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26: 137-143
26. Feng M, Whitesall S, Zhang Y, et al. Validation of volumepressure recording tail-cuff blood pressure measurements. Am J Hypertens 2008; 21: 1288-1291
27. Fraser TB, Turner SW, Mangos GJ, et al. Comparison of telemetric and tail-cuff blood pressure monitoring in adrenocorticotrophic hormone-treated rats. Clin Exp Pharmacol Physiol 2001; 28: 831-835
28. Santos RA, Simoes e Silva AC, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein- coupled receptor Mas. Proc Natl Acad Sci 2003; 100: 8258-8263
29. Porsti I, Bara AT, Busse R, et al. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 1994; 111: 652-654
30. Grobe JL, Mecca AP, Mao H, et al. Chronic angiotensin-( 1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 2006; 290: H2417-H2423
31. Ferrario CM, Trask AJ and Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005; 289: H2281-H2290
32. Hayashi N, Yamamoto K, Ohishi M, et al. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells. Hypertens Res 2010; 33: 1182-1185
33. Pinheiro SV, Ferreira AJ, Kitten GT, et al. Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney Int 2009; 75: 1184-1193
34. Sampaio WO, Nascimento AA and Santos RA. Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am J Physiol Heart Circ Physiol 2003; 284: H1985-H1994
35. Dharmani M, Mustafa MR, Achike FI, et al. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin- induced diabetic rats. Eur J Pharmacol 2007; 561: 144-150
36. Gross V, Schunck WH, Honeck H, et al. Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int 2000; 57: 191-202
37. Chang SY, Chen YW, Chenier I, et al. Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. Exp Diabetes Res 2011; 2011: 521076
38. Koulis C, Chow BS, McKelvey M, et al. AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy. Hypertension 2015; 65: 1073-1081
39. Whelton PK and Klag MJ. Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence. Hypertension 1989; 13: I19-I27
40. Sabuhi R, Ali Q, Asghar M, et al. Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: Opposing effects in lean and obese Zucker rats. Am J Physiol Renal Physiol 2011; 300: F700-F706
41. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-750
42. Kim JH, Xie J, Hwang KH, et al. Klotho may ameliorate proteinuria by targeting TRPC6 channels in podocytes. J Am Soc Nephrol. May 5 2016. DOI: 10.1681/ASN.2015080888
43. Patel SN, Ali Q and Hussain T. Angiotensin II type 2-receptor agonist C21 reduces proteinuria and oxidative stress in kidney of high-salt-fed obese Zucker rats. Hypertension 2016; 67: 906-915